Hazem Altamari

“Revenue/GTM leader with ~10 years of experience scaling companies from early stage through IPO, with unusually deep cross-functional exposure across risk, finance, product/tech, and DevOps. At Catapult, helped drive a pivot from brick-and-mortar to e-commerce and landed major enterprise customers (Lenovo and Wayfair) by navigating complex system integrations and enterprise delivery expectations. Previously ran a family business (2004–2008) and is committed to founding a company.”

Evan Tobias

Screened

Director-level sales leader specializing in Enterprise SaaS and strategic partnerships

New York, NY20y exp

“Sales leader who was the first Director of Sales at Statista and built the function from the ground up, scaling the team from 6 to 27 and ARR from $5M to $33M in five years. Brings strong public sector and healthcare sales experience, including a $500K Kaiser Permanente deal, plus hands-on expertise implementing CRM/process infrastructure and creating new verticals that doubled revenue.”

Samuel Lee

Screened

Executive Sales Leader specializing in Enterprise SaaS GTM and global revenue growth

Hoboken, NJ14y exp

“Revenue/sales operations and GTM builder for early-stage startups who designs repeatable sales processes (CRM pipeline stages, MEDDPICC, Challenger Sales) and operating cadences (OKRs) to improve conversion and forecasting. Also mentors product/technical founders—e.g., through the Canadian Technology Accelerator—helping a fintech founder establish segmentation, metrics, and an outbound motion that produced early recurring revenue and investor readiness.”

Bryan DiMenna

Screened

Executive Revenue & Sales Leader in Life Sciences, Specialty Chemicals, and Retail Channels

St. Augustine, FL20y exp

“Innovation and licensing leader (formerly led global rapid innovation at BASF) with 10+ years interfacing with top-tier universities and Fortune 100 companies across pharma/biologics, aerospace/defense, and chemicals. Currently drafting provisional patents and guiding lab validation from computational biology toward bench-scale proof of concept for a DARPA-grant-aligned venture targeting >90% margins in a rapidly growing market.”